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Quality of lifeBenign gynecological conditions impact on women's lives in a myriad of ways. Many of these conditions exert
their burden on women's health because they remain undiagnosed, unacknowledged, or unreported for many
years. Some of these conditions cause debilitating primary symptoms, especially of heavy menstrual bleeding,
the lethargy of iron deﬁciency, and of persistent pelvic pain, with substantial impact on quality of life and ability
to function on a day-to-day basis. The distressing quality of life impact of pelvic ﬂoor prolapse or of local vulval
lesions shouldnot be overlooked.Many also have secondary health consequenceswith adverse effects on fertility
and reproductive outcome.
© 2012 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.1. Introduction
The impact of benign gynecological conditions on both general and
reproductive health is largely ignored in many low-resource settings,
yet these conditions often determine a woman's likelihood of being in-
fertile, her ability to cope with the daily demands of managing a family,
her ability as a sexual partner, her chance of entering pregnancy when
anemic, and her ability to cope with complications that may develop
during pregnancy. These gynecological conditions are common in all
societies, but the pattern of disease varies considerably from one geo-
graphical and cultural region to another, although documentation of
these in particular communities is often lacking [1].
Theremay be a very high prevalence of serious reproductive disease
in some rural village environments. In a study carried out by the Popu-
lation Council in 1992–1993, in a sample of 509 parous and nongravid
women from 2 Egyptian villages, a detailed medical survey found that
56% of these women had genital prolapse, 52% had reproductive tract
infections (44% vaginitis, 19% pelvic inﬂammatory disease), and 11%
had abnormal cervical cell changes. Additionally, anemia was present
in 63% of the women, while 14% had a urinary tract infection, 18%
were hypertensive, and 43% were obese (19% grossly obese). In this
community most of the men and women had no schooling [2].
The limited number of early studies of benign reproductive and
gynecological disease in rural communities was greatly hindered by
the “culture of silence” about reproductive matters [1] and the con-
cept of “secret women's business,” such as exists in many Aboriginal
communities [3,4]. Even when studies were carried out by femaleGynecology and Neonatology,
and Infants, The University of
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eration of Gynecology and Obstetrics.physicians already working in the local health centers of many study
communities, a high rate of gynecological pelvic examinationswas usu-
ally not possible [5].
Most of the earlier studies of reproductive disease in rural and low-
resource communities have focused on sexually transmitted infections
because of the fertility implications and the need for contraception.
More recently, an even greater focus on sexual transmission of HIV/
AIDS in low-resource communities [6] has diverted attention from the
burden of other gynecological conditions in these same communities.
A study undertaken in rural Egypt by the Population Council identi-
ﬁed a range of determinants of reproductive morbidity in low-resource
settings [2,7]. The conceptual framework developed to account for the
multiple individual and sociocultural factors that can impact on a
woman's reproductive health is represented in Fig. 1.
2. Deﬁnitions
In this paper, the term “benign gynecological disorders” is taken to
exclude premalignant forms of endometrial hyperplasia, cervical intra-
epithelial neoplasia, and conﬁrmed malignant disease of the reproduc-
tive tract. The main symptoms and underlying diseases relevant to this
manuscript are summarized in Table 1.
3. The impact of gynecological symptoms
The primary impact of gynecological disease in low-resource settings
comes through the occurrence of acute episodes of excessively heavy
vaginal bleeding or acute pelvic pain. These symptoms are usually toler-
ated and coped with until the severity is such that it leads to an inability
to carry out daily household tasks or to physical collapse.
Inmany rural communities, perceivedheavy vaginal bleeding or pel-
vic painwill initially bemanagedwith infusions fromherbalmixtures orPublished by Elsevier Ireland Ltd. All rights reserved.
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Fig. 1. Determinants of reproductive morbidity (modiﬁed from Younis et al. [2]).
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seen to possess special powers. Many such recipes exist in different cul-
tures. The Chinese Barefoot Doctor's Manual recommends using a com-
bination of 4 plants, including Gardenia ﬂorida for the treatment of
painful periods associated with heavy menstrual ﬂow [8]. In China
today, traditional herbal treatments are commonly used to treat the
symptoms associated with ﬁbroids [9].
4. Impact of heavy menstrual bleeding
One of the most common gynecological symptoms involves
“perceived” heavy menstrual bleeding (HMB). The word “perceived”
is used because there are no reliable means of assessing absolute rate
and volume of blood loss in these low-resource clinical situations. In
many low-resource settings, women appear to tolerate a heavier loss
than in high-resource societies because a heavy “red” loss is perceived
as a healthy “clean out” of body impurities. This tolerance of heavy
bleeding probably accounts for the surprising report that the objectively
measuredmean formenstrual blood loss (MBL) in a Chinese Communi-
tywas 56 mL [10] compared withmeans of 30–35 mL reported in high-
resource communities [11]. In high-resource settings, many of these
women would, much earlier, have been identiﬁed, classiﬁed, and treat-
ed as being heavy bleeders. The original “norms” from high-resource
settings were based on objective menstrual blood loss measurements
combined with hematological parameters, with the upper limit of the
normal MBL range determined by a signiﬁcant drop in hemoglobin
and serum iron parameters [11]. Objective MBL has not been deter-
mined in such a manner in low-resource settings.
In many cultures, HMB is ignored and myths about management
persist. South Asian women with heavy periods often avoid the iron-
rich foods they most need [12]. Issues of menstruation are considered
very personal and secretive and there is great reluctance across many
cultures from South Asia to Africa to discuss the problem, even with
health professionals [12,13]. As mentioned above, in many low-
resource settings, menstruation is widely accepted as having a natural,Table 1
Main symptoms and underlying diseases relevant to benign gynecological disorders.
Symptoms Benign disorders
Heavy menstrual bleeding
(with associated iron
deﬁciency and anemia)
Endometrial molecular pathway disturbances
Uterine ﬁbroids (leiomyomas)
Endometrial polyps
Adenomyosis
Endometriosis (coagulopathies)
Pelvic pain Pelvic inﬂammatory disease
Ectopic pregnancy
Endometriosis
Uterine ﬁbroids (leiomyomas)
Benign ovarian masses
“Irritable bowel” symptoms; diverticulitis
Interstitial cystitis
Dragging, heavy pelvic sensation,
lump in vagina
Uterine and/or vaginal wall prolapse
Urinary incontinence
Fecal incontinencecleansing effect, and therefore a heavy loss may be accepted as a mark
of well-being, and access to treatment is delayed [14]. These cultural
differences, allied with a lack of trained human resources and limited
health clinic facilities, mean that most women with heavy vaginal
bleeding will defer presentation to a health facility until an episode is
“acute and severe.” The limited availability of resources means that
management is usually limited to an attempt at diagnosis combined
with therapy targeted at stopping the acute bleeding—usually some
form of curettage. The patient usually needs to be managed at a single
visit, since she may have limited possibilities of returning to the clinic
because of family duties and distance.
HMB is often associated with a complex of symptoms and the bur-
den of the condition extends into many aspects of women's lives
through the practical difﬁculties of excessive blood loss and having to
curb normal social, cultural, and religious activities [15,16]. When
neglected, HMB can lead to iron deﬁciency (with or without anemia)
that results in chronic symptoms of fatigue, increased susceptibility to
infections, and poor wound healing [17]. These symptoms may occur
with iron deﬁciency on its own, even in the absence of anemia. Anemia
exposes reproductive-agedwomen to an increased chance of complica-
tions in pregnancy and labor including preterm birth and postpartum
hemorrhage (PPH), and signiﬁcantly increases the risk of dying in child-
birth, especially with PPH [18].
HMB can arise from an imbalance in the clotting and bleeding fac-
tors at a local level within the endometrium. Although considered rare
in most low-resource settings, inherited coagulopathies, such as von
Willebrand Disease, are challenging to manage because of limitations
in diagnostic facilities and therapeutic options [19]. High rates of con-
sanguineous marriages can increase the chance of some of the rarer
bleeding disorders that can lead to HMB [20].
HMB can also occur with a number of benign gynecological condi-
tions including leiomyomas (ﬁbroids), polyps, and adenomyosis. Around
one-third of women with symptomatic ﬁbroids experience abnormal
bleeding, most commonly irregular or HMB. Fibroids occur more fre-
quently in women who are nulliparous or overweight, and in African
American and Black African women who have larger and more numer-
ous ﬁbroids; as a consequence, they experience more severe symptoms
compared with women of other races.
Fibroids are responsible for one-third of all gynecological admissions
and are the most common indication for hysterectomy in low-resource
settings [21,22]. One of the key factors impacting on the burden of
ﬁbroid-associated disease is that until relatively recently, surgery has
been the main option for treatment. Furthermore, the modern medical
treatments available to women in high-resource countries are not on
offer in low-resource settings and thus many women have little choice,
particularly if they want to maintain fertility.
Over the past 8 years, FIGO has had a major input into the under-
standing ofmany aspects of abnormal uterine bleeding (AUB), but espe-
cially HMB, through the establishment of the FIGOMenstrual Disorders
Working Group [23].5. Impact of chronic pelvic pain
Inmost low-resource settings, chronic pelvic pain is associated with
chronic pelvic inﬂammatory disease (PID), resulting from a high rate of
exposure to sexually transmissible organisms, especially chlamydia and
gonorrhea [24–26]. This, in turn, is associatedwith a high rate of prima-
ry and secondary tubal infertility, with a prevalence in some African
communities as high as 30% [27–30]. Furthermore, womenwith a histo-
ry of PID have 6–10 times the risk of developing an ectopic (tubal) preg-
nancy compared with women with no history of pelvic infection. Of all
ectopic pregnancies, 40%–50% can be attributed to previous PID [31].
Endometriosis is probablymore common in these low-resource settings
than generally recognized, but data are not available because of the dif-
ﬁculties of diagnosis in these settings.
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recognized presentations of PID, such as irregular or postcoital bleeding
and urinary frequency, and treatment that recognizes the polymicrobial
nature of many cases. Primary prevention through screening and treat-
ment for chlamydia infection is optimal [32].
Chronic pelvic pain is not treated with a great deal of sympathy in
most societies. It is a symptom that cannot be objectively veriﬁed, and
underlying causes usually require the availability of imaging technology
or endoscopic facilities. Management is usually unsatisfactory and indi-
vidual sufferers need to develop their own coping mechanisms within
their own personal environment.
Although chronic PID is the most common cause of severe pelvic
pain in low-resource settings, it is likely that undiagnosed endometri-
osis also plays an important role. For example, general practitioners in
Nigeria infrequently refer women for gynecological review and have
been found to have limited knowledge of the options for investigation
andmanagement of endometriosis [33]. Less common causes of chronic
pelvic pain include interstitial cystitis and irritable bowel syndrome. Fi-
broids can also result in pelvic or back pain, along with abdominal
swelling and/or pressure symptoms, especially in low-resource settings
where there is late presentation and the ﬁbroid(s) has grown large [22].
The incidence and importance of adenomyosis as a cause, or contribut-
ing cause, of pelvic pain in low-resource settings are unknown.
6. Pelvic organ prolapse
Pelvic organ prolapse is very common in parous women and in-
creases with the number of vaginal births. In some women the damage
to the pelvic ﬂoor that occurs with childbirth also leads to urinary and
fecal incontinence. In middle- and low-income countries around 20% of
women experience pelvic organ prolapse, one-third experience urinary
incontinence, and 7% fecal incontinence [34]. Prolapse development is
multifactorial, but themost consistently reported risk factors are (multi-
ple) vaginal childbirth, advancing age, and increased body mass index.
Additional factors can include poor nutrition and heavy manual work
(Box 1) [35,36].
The symptoms that women commonly experience with prolapse in-
clude a dragging heavy sensation, a mass in the vagina, and lower back-
ache. The presence of such prolapsing organs can affect women's sexual
lives and impact on their ability towork. Those reporting urinary incon-
tinence frequently experience a multitude of adverse effects on quality
of life, including an adverse impact on self-esteem, sexual intercourse,
and activities of daily living. The condition imbues womenwith feelingsBox 1
Risk factors for pelvic organ prolapse.
Established
• Vaginal delivery (especially multiple deliveries)
• Advancing age
• Obesity
Potential risk factors
• Obstetric factors
- Pregnancy (irrespective of mode of delivery)
- Forceps delivery
- Young age at ﬁrst delivery
- Prolonged second stage of labor
- Infant birth weight >4500 g
• Mother with a history of pelvic organ prolapse
• Poor nutrition
• Work involving heavy lifting
• Constipation
• Connective tissue factorsof shame and embarrassment about the accompanying distressing odor,
and leaves them feeling constantly unclean—an even greater problem in
low-resource settings than in industrialized countries [35].
7. Impact of other gynecological symptoms
There is limited information on other gynecological symptoms, such
as premenstrual “syndrome,” that may be important in low-resource
settings. Cyclical menstrual symptoms (such as premenstrual mood
symptoms, “the PMS syndrome,” or premenstrual dysphoric disorder
[PMDD]) are a signiﬁcant part of overall benign gynecologicalmorbidity
in industrialized countries, but there are fewdata on the occurrence and
impact of such symptoms in low-resource settings. Medical conditions
that are exacerbated by or occur in phase with the menstrual cycle
vary from the common (premenstrual exacerbation of asthma and
menstrual migraine) to the exceptionally rare (catamenial pneumotho-
rax, autoimmune progesterone dermatitis, and cyclical thrombocytope-
nia). It seems probable that the majority of these conditions are less
common in low-resource communities. Management and prevention
of these conditions are also highly variable in different cultures;
hence, assessment of the burden of health raised in such cultures by
these conditions is very difﬁcult to calculate. Nevertheless, even if
these conditions are rarely “visible” in such low-resource settings, it
does not mean that they are absent. They may be important in terms
of efﬁcient functioning for a small number of women in each culture.
Vesicovaginal ﬁstula remains, largely, an overlooked problem in
many countries as it affects the most marginalized members of society:
young, poor, illiterate women who live in remote areas. The formation
of obstetric ﬁstulae is a result of complex interactions of social, biologic,
and economic inﬂuences [37]. Obstetric ﬁstulae with urinary inconti-
nence are associatedwith physical and social deprivation, such as exclu-
sion from the family and violent reactions from the woman's husband
[38]. These ﬁstulae and the need for a global obstetric ﬁstula training
strategy are the subject of a much more detailed article elsewhere in
this Supplement [39].
8. The impact of gynecological disorders on reproductive outcome
Many gynecological conditions, if left untreated, can have a signiﬁ-
cant impact on pregnancy outcomes and on delivery of care to women
in low-resource settings [40,41]. UntreatedHMB can result in signiﬁcant
anemia. A hemoglobin level below 5 g/dL is associated with an 8 to 10-
fold increase in the maternal mortality ratio for women. Maternal ane-
mia also has a signiﬁcant impact on fetal growth and well-being [18].
Fibroids can impact on pregnancy in a number of ways. They can un-
dergo degeneration as they grow under the inﬂuence of pregnancy hor-
mones and cause acute pain. They can also impinge on theuterine cavity
and complications repeatedly associated with ﬁbroids include placental
previa, malpresentations such as breech, and increased rates of opera-
tive delivery and cesarean delivery [41].
Infertility, arisingmainly from infection-related tubal causes, results
in severe emotional suffering in low-resource settings. Women and
men experience diverse social, economic, and personal effects, which
go beyond childlessness, and women bear the major burden [42].
9. Summary and conclusions
Certain benign gynecological disorders, such as uterine ﬁbroids,
chronic PID, ectopic pregnancy, pelvic ﬂoor prolapse, and obstetricﬁstula
are very common inmany low-resource settings and contribute substan-
tially to femalemorbidity and inability to contribute to the family and so-
ciety. These and other related disorders usually present with excessively
heavy menstrual bleeding (or the lethargy that is associated with iron
deﬁciency and anemia) or pelvic pain—two symptoms that may greatly
inﬂuence women's ability to manage day-to-day life requirements. The
provision of health facilities and the training of local health personnel
S75K.I. Black, I.S. Fraser / International Journal of Gynecology and Obstetrics 119 (2012) S72–S75sufﬁcient to meet these needs in each community is a challenge that
faces all government and international aid bodies in low-resource coun-
tries currently lacking such a network.
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